A Phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases-Reference-Cited by-同舟云学术

A Phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

Published:2003-01-23 Issue:S3 Volume:97 Page:887-892
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Body Jean-Jacques,Greipp Philip,Coleman Robert E.,Facon Thierry,Geurs Filip,Fermand Jean-Paul,Harousseau Jean-Luc,Lipton Allan,Mariette Xavier,Williams Catherine D.,Nakanishi Arline,Holloway Donna,Martin Steven W.,Dunstan Colin R.,Bekker Pirow J.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference17 articles.

1. Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

2. Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.

3. Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases

4. Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial

5. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.

Cited by 324 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells;Cell Death Discovery;2024-08-24

2. Engineering small-molecule and protein drugs for targeting bone tumors;Molecular Therapy;2024-05

3. The RANK–RANKL–OPG System: A Multifaceted Regulator of Homeostasis, Immunity, and Cancer;Medicina;2023-09-30

4. Insight into the molecular mechanism of action of anticancer drugs;How Synthetic Drugs Work;2023

5. Investigation on Controlling Therapy of Bone Skeletal and Marrow Cancer: A Biophysical Chemistry and Molecular Dynamic Study of Bisphosphonates Interaction with Bone Structures;Biointerface Research in Applied Chemistry;2022-11-01